2
Views
1
CrossRef citations to date
0
Altmetric
Letter To Editor

Letter to the Editor: “Aripiprazole and Haloperidol: A Clinically Relevant Interaction with a Dopamine Antagonist and Partial Agonist”

&
Pages 129-130 | Published online: 04 Dec 2011

References

  • Lieberman JA: Dopamine partial agonists: a new class of antipsy-chotic. CNS Drugs 2004; 18:251–267
  • Physicians Desk Reference 58th Edition (2004): Abilify (aripipra-zole) package insert (revised May 2003), 1034–38
  • Burris KB, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, et al.: Aripiprazole, a novel antipsychotic, is a high-affinity partial ago-nist at human dopamine D2 receptors. Pharmacol and Exp Ther 2002; 302: 381–389
  • Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, et al.: Radioreceptor binding profile of the atypical antip-sychotic olanzapine. Neuropsychopharmacology 1996; 14:87–96
  • Stephens DN, Loschmann PA, Lanzinger C, Wachtel H, Montgomery A, Herberg LJ: Unusual interactions between the neuroleptic haloperidol and the dopamine D2 partial agonist, terguride. Behav Pharmacol 1990; 1:521–529

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.